InVivoMab anti-mouse PD-L2 (B7-DC) BE0112-R001mg from Bio X Cell

Product Specs
ItemInVivoMab anti-mouse PD-L2 (B7-DC)
CompanyBio X Cell
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBE0112-R001mg
Quantity1 mg
Applicationsin vivo PD-L2 blockade, in vitro PD-L2 blockade, Immunohistochemistry (frozen), Flow cytometry
ConcentrationLot specific,typically between 4-11 mg/ml
Conjugate/TagUnconjugated
ReactivityMouse
TargetPD-L2
IsotypeIgG2a, κ
CloneTY25
Hostrat
NCBI Full Gene Nameprogrammed cell death 1 ligand 2
NCBI Gene AliasesB7-DC, Btdc, F730015O22Rik, PD-L2
ClonalityMonoclonal
ImmunogenMouse PD-L2 transfected cell line
Antibody TypePrimary Antibody
Purity>95%, Determined by SDS-PAGE
FormatPBS, pH 7.0, Contains no stabilizers or preservatives
Research AreaCancer Biology, Immune Checkpoint Protein, Immunology

Other available quantities: Available in 1, 5, 10, 25, 50, 100 mg and bulk sizes. Academic discount available.

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

(1) Programmed death-1 controls T cell survival by regulating oxidative metabolismJournal of immunology (Baltimore, Md. : 1950)June 15, 2015Tkachev V, Goodell S, Opipari AW, Hao LY, Franchi L, Glick GD, Ferrara JL, Byersdorfer CA.

(2) PD-1 suppresses protective immunity to Streptococcus pneumoniae through a B cell-intrinsic mechanismJournal of immunology (Baltimore, Md. : 1950)March 1, 2015McKay JT, Egan RP, Yammani RD, Chen L, Shin T, Yagita H, Haas KM.

(3) Both PD-1 ligands protect the kidney from ischemia reperfusion injuryJournal of immunology (Baltimore, Md. : 1950)January 1, 2015Jaworska K, Ratajczak J, Huang L, Whalen K, Yang M, Stevens BK, Kinsey GR.

(4) Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfectionJournal of immunology (Baltimore, Md. : 1950)November 15, 2014Erickson JJ, Rogers MC, Hastings AK, Tollefson SJ, Williams JV.

(6) Th2 cell-intrinsic hypo-responsiveness determines susceptibility to helminth infectionPLoS pathogensMarch 1, 2013van der Werf N, Redpath SA, Azuma M, Yagita H, Taylor MD.

InVivoMab anti-mouse PD-L2 (B7-DC)